Will You Regain Weight After Stopping Semaglutide?

If you are taking semaglutide — or thinking about it — this is the question that matters most for the long run: what happens when you stop? The honest, evidence-based answer is that most people regain a large share of the weight they lost. That is not a flaw in the drug or a sign you failed; it is what the best trial data show, and it reflects the biology of obesity. Here are the actual numbers, and what they do and don't mean for you.

The short answer, with the real numbers

The clearest data come from the STEP 1 trial extension, which followed a subset of participants for a full year after they stopped semaglutide 2.4 mg (and stopped the lifestyle support that came with the trial). The findings are specific and worth stating exactly:

• •On semaglutide, participants lost an average of 17.3% of body weight by week 68¹.
• •In the year after stopping, they regained 11.6 percentage points of that lost weight by week 120¹.
• •That left a net loss of about 5.6% from their starting weight a year after withdrawal¹.

In the trial authors' own summary: one year after stopping, participants regained roughly two-thirds of their prior weight loss¹. The cardiometabolic improvements they had gained — in blood pressure, blood lipids, and blood-sugar markers — also drifted back toward baseline over that same year¹. So it is not only the scale that reverses; much of the metabolic benefit goes with it.

A few honest caveats about these numbers. The extension was an exploratory analysis of a subset (327 participants), not the full trial, so treat the exact figures as a strong signal rather than a precise prediction for any one person¹. And note what it does not say: it does not say everyone regained everything. The average person kept off a meaningful slice (that ~5.6% net), and individual results varied widely — some held onto more, some less.

Why the weight comes back — it is the condition, not willpower

This pattern is not a sign you "did it wrong." Obesity is a chronic condition in which the body actively defends a higher weight. As the Endocrine Society's scientific statement on obesity pathogenesis describes, body weight is regulated around a biologically defended level, and losing weight triggers hormonal and metabolic responses that push to restore it². That defense can persist for years — the long-term follow-up of "The Biggest Loser" contestants found their resting metabolism stayed suppressed six years later³.

Semaglutide works by counteracting some of the appetite signals that drive eating⁴. While you take it, those signals are dampened and you eat less without white-knuckling it. Stop the drug, and the appetite signals it was suppressing return — so hunger comes back and, for most people, weight follows. In that sense semaglutide behaves like medicines for other chronic conditions: blood-pressure medication does not cure hypertension, and stopping it lets the pressure climb again. The STEP 1 extension authors drew exactly this conclusion, noting the findings "confirm the chronicity of obesity" and suggest ongoing treatment is needed to maintain the benefit¹.

The mirror image: staying on it holds the loss

The flip side of the regain data is just as informative — and more encouraging. The STEP 4 trial tested continuation directly. After a 20-week run-in on semaglutide, participants were split: those who continued the drug went on to lose or maintain weight, while those switched to placebo regained it⁵. The longer-term picture backs this up: in the four-year SELECT analysis, weight loss was sustained for years on continued treatment, plateauing but largely holding rather than rebounding⁶. And SELECT showed semaglutide reduced major cardiovascular events over that time⁷ — a benefit tied to staying on the drug, not a one-time prize.

Together, STEP 1's extension and STEP 4 tell one consistent story: the benefit lasts as long as the treatment does.

What stopping actually feels like

People sometimes brace for a sudden "rebound" the day they stop, but that is not how it goes. Because semaglutide is long-acting, it clears from your system gradually over several weeks, so appetite returns slowly rather than overnight. What most people describe is hunger creeping back and old eating patterns becoming easier to fall into, with the scale following over the months that follow — consistent with the gradual, year-long regain seen in the STEP 1 extension¹. The practical upside: it is not an instant switch, which gives you and your clinician a window to plan. We walk through the experience in more depth in what happens when you stop semaglutide.

Can you keep the weight off without the drug?

It is a fair hope, but the trial evidence is sobering. In the STEP 1 extension, participants regained most of their lost weight even though lifestyle support had been part of the trial — because the medicine had been doing real biological work that diet and exercise alone did not fully replace¹. That does not make healthy habits pointless: they are valuable for overall health and may soften regain. But they should not be sold as a guaranteed substitute for the drug's effect. Two things that genuinely help blunt regain and protect your metabolism:

• •Preserve muscle. A meaningful share of weight lost on semaglutide is lean mass, and losing muscle lowers the metabolism that resists regain. Protein and resistance training help — see will semaglutide make you lose muscle?.
• •Have a transition plan. Coming off should be a deliberate, prescriber-guided process — possibly a taper or a bridge strategy — not an abrupt stop. The decision is individual, weighed against your goals and situation.

Does this mean you can never stop?

No. The data describe what happens on average when people stop, not a rule that stopping is forbidden. People come off semaglutide for side effects, cost, pregnancy planning, or because their clinical picture changes — and some keep off more than the average. The point is to go in with realistic expectations: for most people, holding the results means staying on the medication, and stopping usually brings a substantial portion of the weight back. Reaching a stable weight-loss plateau while on the drug is a normal, good outcome — and a completely different thing from the regain that follows stopping. Whether and how to come off is a conversation for your prescriber, not a solo decision.

The honest bottom line

Based on the STEP 1 extension, the most likely outcome of stopping semaglutide is regaining about two-thirds of your lost weight within a year — concretely, around 11.6 of every 17.3 percentage points lost, leaving a net ~5.6% — with metabolic improvements fading too¹. Staying on it preserves the benefit, as STEP 4 and the four-year SELECT data show⁵⁶. Semaglutide is an FDA-approved, well-evidenced treatment, but it treats a chronic condition, which usually means ongoing use. Because that turns the cost into a standing, indefinite expense, the regain math is central to whether the drug is worth it — see Is Wegovy worth it? An honest cost-benefit look. For the full evidence picture see Semaglutide: How It Works, Results & Side Effects; for the lived experience of stopping see what happens when you stop semaglutide; and if you are weighing providers, our best semaglutide providers guide ranks options on price and oversight.